Abstract

An anti-HBc assay will be developed based on a different principle than all current available tests. This new assay will be used to assist the decision-making process of blood donor exclusion. The test also will be adaptable to analyze the specificity of HBcAg preparations made by different recombinant DNA procedures and the native viral core antigen.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL002051-03
Application #
3916487
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost

  Institution

Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code